Omeros Corporation (OMER)
NASDAQ·Healthcare·Biotechnology
$14.61
-0.88%
Mkt Cap $974.11M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $1.60M | — | — | -$0.55 | $3.14 | +670.91% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.58 | -$0.19 | +67.24% | — | — |
| Q3 2025 Aug 14, 2025 | $312.50K | — | — | -$0.55 | -$0.53 | +3.64% | — | — |
| Q2 2025 May 15, 2025 | $416.67K | — | — | -$0.57 | -$0.65 | -14.04% | — | — |
| Q1 2025 Mar 31, 2025 | — | $412.00K | — | -$0.78 | -$0.63 | +19.23% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.70 | -$0.64 | +8.57% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$1.14 | -$1.12 | +1.75% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.58 | -$0.74 | -27.59% | — | — |
| Q2 2024 Apr 1, 2024 | — | $1.37M | — | -$0.56 | -$0.63 | -12.50% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.62 | -$0.82 | -32.26% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.60 | -$0.70 | -16.67% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.55 | -$0.63 | -14.55% | — | — |
| Q1 2023 Mar 13, 2023 | — | — | — | -$0.57 | -$0.73 | -28.07% | — | — |
| Q4 2022 Nov 9, 2022 | $2.79M | — | — | -$0.61 | -$0.87 | -42.62% | — | — |
| Q3 2022 Aug 9, 2022 | — | $10.10M | — | -$0.68 | -$0.60 | +11.76% | — | — |
| Q2 2022 May 10, 2022 | $10.21M | $27.70M | +171.24% | -$0.74 | -$0.56 | +24.32% | — | — |
| Q1 2022 Mar 1, 2022 | $66.92M | $79.89M | +19.38% | -$0.30 | -$0.37 | -23.33% | — | — |
| Q4 2021 Nov 9, 2021 | $30.15M | $30.00M | -0.48% | -$0.45 | -$0.26 | +42.22% | — | — |
| Q3 2021 Aug 9, 2021 | $22.99M | $28.82M | +25.37% | -$0.50 | -$0.40 | +20.00% | — | — |
| Q2 2021 May 10, 2021 | $21.06M | $21.06M | +0.00% | -$0.51 | -$0.50 | +1.96% | — | — |